newsfilter
← Latest News
GlobeNewswire·

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting

End of Phase 2 Meeting has been Rescheduled for July 29th Meeting to Discuss Upcoming Clinical Development Plan and Protocol Designs Strategic Partnership Discussions Expected to Accelerate Following a Positive FDA